PVG Premier Veterinary Group Plc

TIDMAKT

RNS Number : 6395A

Ark Therapeutics Group PLC

02 April 2012

ARK THERAPEUTICS GROUP PLC

31 March 2012

Annual Information Update

Ark Therapeutics Group plc (the "Company") is pleased to provide an annual information update in accordance with the requirements of Prospectus Rule 5.2. This update refers to information that has been published or made available by or for the Company to the public in the 12 months up to and including 31 March 2012.

The following UK regulatory announcements have been made via the Regulatory News Service provided by the London Stock Exchange:

 
 Date                Headline 
 
 31 March 2011       Annual Information Update 
 9 May 2011          AGM Results 
 17 May 2011         Interim Management Statement 
 3 June 2011         Block Listing Interim Review 
 13 June 2011        Price Monitoring Extension 
 13 June 2011        Second Price Monitoring Extension 
 4 July 2011         Grant of US Patents and Milestone Payments 
 6 July 2011         Ark receives Finnish Grants 
 14 July 2011        Wins EUR5.3 million EU Framework Programme 7 Grant 
 18 July 2011        Holding(s) in Company 
 25 July 2011        Price Monitoring Extension 
 25 July 2011        Second Price Monitoring Extension 
 29 July 2011        Price Monitoring Extension 
 29 July 2011        Second Price Monitoring Extension 
 1 August 2011       Holding(s) in Company 
 24 August 2011      Half Yearly Report - Part 1 
 24 August 2011      Half Yearly Report - Part 2 
 24 August 2011      Half Yearly Report on National Storage Mechanism 
 12 September 2011   Re: Agreement 
 16 September 2011   Price Monitoring Extension 
 16 September 2011   Second Price Monitoring Extension 
 3 November 2011     Manufacturing Agreement 
 9 November 2011     Interim Management Statement 
 5 December 2011     Block Listing Interim Review 
 7 December 2011     Director/PDMR Shareholding 
 4 January 2012      Manufacturing update 
 16 January 2012     Change of Broker 
 8 February 2012     US Patent for Neuropilin-1 Receptor 
 9 February 2012     Notice of Results 
 23 February 2012    Holding(s) in Company 
 12 March 2012       Final Results 
 13 March 2012       Board Changes 
 15 March 2012       Director/PDMR Shareholding 
 26 March 2012       Change of Broker Name 
 

Copies of all regulatory announcements for Ark Therapeutics Group plc can be found on the Press Release Archive page on the Company's website www.arktherapeutics.com

Documents sent to shareholders and filed with the UKLA Document Viewing Facility (now the National Storage Mechanism):

 
 Date of Filing   Document 
 
 10 May 2011      2011 AGM Resolutions 
 24 August 2011   2011 Interim Report 
 21 March 2012    Annual Report and Accounts for the year ended 
                   31 December 2011 (including Notice of 2012 Annual 
                   General Meeting) 
 21 March 2012    2012 Annual General Meeting Proxy form 
 

Documents filed with the UKLA's National Storage Mechanism can be obtained from: www.hemscott.com/nsm.do.

The 2011 AGM Resolutions and 2011 Annual Report and Accounts are also available either on the Company's website www.arktherapeutics.com or, as well as the other documents listed above, on application to the Company Secretary.

The Company has also made the following filings at Companies House:

 
 Date of Filing    Document filed 
 
 10 May 2011       2011 AGM Resolutions 
 10 May 2011       Form AD01 - Change of Registered Office 
 10 May 2011       Form CH01 - Change of Directors Details 
 10 May 2011       Form CH01 - Change of Directors Details 
 10 May 2011       Form CH01 - Change of Directors Details 
 10 May 2011       Form CH01 - Change of Directors Details 
 10 May 2011       Form CH01 - Change of Directors Details 
 2 November 2011   Form CH01 - Change of Directors Details 
 2 November 2011   Form AR01 - Annual Return 
 14 March 2012     AP01 - Appointment of Director 
 

Copies of these documents may be obtained from Companies House, Crown Way Maindy, Cardiff CF14 3UZ or through Companies House Direct at www.direct.companieshouse.gov.uk.

Further information is available regarding the Company and its activities on its website www.arktherapeutics.com.

The information referred to in this update was up to date at the time the information was published, but some information may now be out of date.

Enquiries:

 
 Ark Therapeutics Group plc 
  Dr Edward Bliss, Company Secretary    020 7388 7722 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

AIUZLLFBLZFLBBZ

Premier Veterinary (LSE:PVG)
Historical Stock Chart
From May 2024 to Jun 2024

Premier Veterinary (LSE:PVG)
Historical Stock Chart
From Jun 2023 to Jun 2024